...
首页> 外文期刊>The Lancet Planetary Health >Associations between habitual flavonoid intake and hospital admissions for atherosclerotic cardiovascular disease: a prospective cohort study
【24h】

Associations between habitual flavonoid intake and hospital admissions for atherosclerotic cardiovascular disease: a prospective cohort study

机译:习惯性黄酮摄入量与动脉粥样硬化性心血管疾病住院率之间的关联:一项前瞻性队列研究

获取原文
           

摘要

BackgroundFlavonoids, compounds found in plant-based foods and beverages, might ameliorate vascular damage and atherosclerosis. Therefore, our aim was to assess the association between flavonoid intake and hospital admissions due to atherosclerotic cardiovascular disease.MethodsIn this prospective cohort study, participants from the Danish Diet, Cancer, and Health Study were cross-linked with Danish nationwide registries. Eligible participants were aged 50–65 years, had no previous history of atherosclerotic cardiovascular disease, and had completed a food-frequency questionnaire at baseline. We examined associations between flavonoid intake (calculated from food-frequency questionnaires with use of the Phenol-Explorer database) and hospital admissions for atherosclerotic cardiovascular disease, ischaemic heart disease, ischaemic stroke, or peripheral arterial disease. We obtained hazard ratios (HRs) using restricted cubic splines based on Cox proportional hazards models.FindingsOf the participants recruited to the Danish Diet, Cancer, and Health study between 1993 and 1997, our study population was comprised of 53?552 participants, with a median follow-up of 21 years (IQR 15–22). During follow-up, 8773 participants were admitted to hospital for atherosclerotic cardiovascular disease. We observed non-linear associations between flavonoid intake and hospital admissions, plateauing at total flavonoid intakes of approximately 1000 mg per day. Compared with an intake of 175 mg per day, an intake of 1000 mg per day was associated with a 14% lower risk of atherosclerotic cardiovascular disease (HR 0·86, 95% CI 0·81–0·91). For disease subtypes, we observed a 9% lower risk of ischaemic heart disease (0·91, 0·85–0·98), a non-significant 9% lower risk of ischaemic stroke (0·91, 0·82–1·01), and a 32% lower risk of peripheral artery disease (0·68, 0·60–0·78). The overall associations were stronger in smokers than in non-smokers, as well as stronger in consumers of high (>20 g per day) quantities of alcohol than in those consuming low-to-moderate (≤20 g per day) quantities.InterpretationOur results suggest that ensuring an adequate consumption of flavonoid-rich foods, particularly in subpopulations at risk of atherosclerosis such as smokers and consumers of high quantities of alcohol might mitigate some of the risk of atherosclerotic cardiovascular disease. More studies are needed to support and validate these data.FundingDanish Cancer Society.
机译:背景类黄酮是植物性食品和饮料中的化合物,可能会改善血管损伤和动脉粥样硬化。因此,我们的目的是评估由于动脉粥样硬化性心血管疾病导致的类黄酮摄入量与入院率之间的关联。方法在这项前瞻性队列研究中,来自丹麦饮食,癌症和健康研究的参与者与丹麦全国注册机构进行了交叉链接。符合条件的参与者年龄在50-65岁之间,以前没有动脉粥样硬化性心血管疾病的病史,并且在基线时完成了食物频率问卷调查。我们检查了类黄酮的摄入量(通过使用Phenol-Explorer数据库通过食物频率问卷计算得出)与住院的动脉粥样硬化性心血管疾病,缺血性心脏病,缺血性中风或外周动脉疾病之间的关联。我们基于Cox比例风险模型使用受限三次样条获得了风险比(HRs)。发现在1993年至1997年之间参加丹麦饮食,癌症与健康研究的参与者中,我们的研究人群由53?552名参与者组成,其中中位随访21年(IQR 15-22)。在随访过程中,有8773名参与者因动脉粥样硬化性心血管疾病入院。我们观察到类黄酮摄入量与住院人数之间存在非线性关联,每天总黄酮摄入量约为1000 mg时达到平稳状态。与每天摄入175 mg相比,每天摄入1000 mg可使动脉粥样硬化性心血管疾病的风险降低14%(HR 0·86,95%CI 0·81-0·91)。对于疾病亚型,我们观察到缺血性心脏病的危险性降低了9%(0·91,0·85-0.98),缺血性中风的危险性降低了9%(0·91,0·82-1 ·01),并使周围动脉疾病的风险降低32%(0·68、0·60-0·78)。与不吸烟者相比,吸烟者的总体关联性强于不吸烟者,并且与每天消费中低度(≤20g)的消费者相比,高数量(> 20 g /天)的消费者更强。结果表明,确保充足食用类黄酮丰富的食物,尤其是在有动脉粥样硬化风险的亚人群(例如吸烟者和大量饮酒的消费者)中,可能会减轻一些动脉粥样硬化性心血管疾病的风险。需要更多的研究来支持和验证这些数据。丹麦基金会癌症基金会。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号